BEYFORTUS
Active substance: nirsevimab
INJECTION · NIRSEVIMAB 100 mg/mL
United StatesActive
Marketing holder: Sanofi Vaccines US Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- NIRSEVIMAB · 100 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-be00-7957-b4ac-b45ab5c158c4,01a1209d-61e3-7ea0-965d-bd6a77126dcc;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 49281-575
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR
Sources
- product · openFDA NDC · 49281-575 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 49281-575 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 49281-575 · Verified 2026-10-09 · open in source